Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 3 of 3 for “"MenAfriVac"”.

  1. Reducing the Burden of Bacterial Meningitis in the African Meningitis Belt After MenAfriVac

    … localized outbreaks, and multiennial epidemics. MenAfriVac, a serogroup A meningococcal conjugate vaccine, was introduced in mass campaigns in 2010 and has significantly reduced carriage and incidence of group A disease across the meningitis belt. However, other meningococcal serogroups and …

    cambridge Repository record for Reducing the Burden of Bacterial Meningitis in the African Meningitis Belt After MenAfriVac (opens in a new tab)

  2. Using mathematical models to evaluate and inform immunisation strategies with MenAfriVac in the African meningitis belt

    … introduction of a tailor-made vaccine, known as MenAfriVac, in these countries through mass campaigns of 1-29 year olds has led to a remarkable decline in the burden of disease due to Neisseria meningitides serogroup A. The aim of this work is to identify immunisation strategies with MenAfriVac

    cambridge Repository record for Using mathematical models to evaluate and inform immunisation strategies with MenAfriVac in the African meningitis belt (opens in a new tab)

  3. Epidemiology and Control of Meningitis in Ghana: Application of Mathematical Modelling

    … including Ghana, have successfully introduced MenAfriVac—a protein-conjugate polysaccharide vaccine targeting N. meningitidis serogroup A (MenA), the predominant cause of epidemics. The vaccine was administered to the high-risk age group (1–29 years), resulting in no confirmed reported cases of …

    cambridge Repository record for Epidemiology and Control of Meningitis in Ghana: Application of Mathematical Modelling (opens in a new tab)